Functional remodelling takes place permanently in the circulatory system. Whether this process also affects the anticontractile effect of the endothelium during vasoconstrictor action is unknown. Therefore, the hypothesis was tested that the impact of the anti-contractile effect of the endothelium on agonist-induced contractions changes during early postnatal development.
Introduction
The circulatory system possesses a high degree of plasticity adapting it to permanently changing conditions. Even established vessels undergo intrinsic changes, i.e. structural and functional remodelling. Structural remodelling is characterized by a rearrangement of the elements of the vascular wall 1 and may occur already after a few hours of permanent constrictor action. 2 In the long term, structural remodelling serves to maintain an altered vascular resistance without proportional changes of the activity of the contractile apparatus. 3, 4 More delicate adaptive changes are observed in the process of functional remodelling characterized by alterations in the relative importance of certain constrictor or dilator signal transduction pathways occurring, for example, with age, during pregnancy, hypertension, and diabetes mellitus. 5, 6 Thus, functional remodelling takes place permanently representing physiological adaptations as well as pathological alterations. Despite its importance, many details of the process of functional remodelling are still unknown.
One of the most attractive models of functional remodelling of the circulatory system is the process of postnatal development, because it † Contributed equally as senior authors. occurs in every individual and reflects physiological plasticity. Maturation of the circulatory system is characterized by a rise in blood pressure and total peripheral resistance associated with growth of vessel networks and a thickening of the wall of individual vessels. Interestingly, in relation to functional remodelling, it was observed that smooth muscle calcium homeostasis as well as calcium sensitivity of the contractile apparatus are altered postnatally. 7, 8 Vascular smooth muscle functional remodelling during postnatal development has been suggested to contribute to the adjustment of blood supply to the changing metabolic demand of growing organs. By releasing a number of vasoactive compounds, the endothelium contributes significantly to the regulation of vascular tone. In particular, endothelium-dependent vasorelaxation opposes the actions of vasoconstrictors and mechanical stimuli. Signal transduction mechanisms governing endothelium-dependent vasorelaxation have been shown to undergo functional remodelling during postnatal development. For example, bradykinin-induced relaxations of pial arteries are mainly prostanoid-dependent in newborn and more NO-dependent in juvenile pigs. 9 In contrast, the influence of basally released NO on vascular resistance declines during the first month of life in swine perfused mesenteric arteries. 10 These and further data 11 show that the process of endothelial functional remodelling during postnatal development varies among vascular beds and is adjusted to the specific requirements for adapting blood supply to changing metabolic demands in a particular organ. Along with endothelium-dependent vasorelaxation, the endothelium has been shown to elicit an anti-contractile effect during vasoconstrictor action. Thus, phenylephrine, which acts only on smooth muscle a 1 -adrenoceptors, increases smooth muscle cell [Ca 2+ ] in that has been proposed to be transmitted to the endothelium, which produces NO and/or endothelium-derived hyperpolarizing factors in vessels from adult animals. 12 The latter effect of phenylephrine induces an endothelium-associated attenuation on its own contraction. Importantly, vasoconstrictor substances, released from nerve endings or delivered by the blood stream, can induce this anti-contractile effect even in the absence of their receptors on the endothelium. 12 Thus, the anti-contractile effect of the endothelium may serve to attenuate vasoconstrictor responses to nervous and humoral stimulation thereby preventing undue blood flow reductions or blood pressure increases. Interestingly, whether the anti-contractile effect of the endothelium also undergoes functional remodelling is unknown. Therefore, the hypothesis was tested that the impact of the anti-contractile effect of the endothelium on agonist-induced contractions changes during early postnatal development.
Methods
A detailed description of all methods can be found in Supplementary material online, Methods.
Animals
Eight to 15 days old ('young') and 2 -3 months old ('adult') male Wistar rats were used. The investigation conforms with the Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85 -23, revised 1996), German Animal Law and regulations at Heidelberg University. The rats were anaesthetized with CO 2 inhalation and then killed by decapitation.
Wire myography
Saphenous and popliteal arteries were isolated and mounted in a myograph (DMT, Denmark, Model 610M) for the recording of isometric force. All vessels were stretched to an internal circumference at which they developed maximal active tension 13 and kept at 378C. Contractile responses were studied after appropriate viability tests during cumulative addition of vasoactive agonists.
Pressure myography
Saphenous arteries from young animals were isolated and mounted in a myograph (DMT, Denmark, Model 201) for the recording of diameter changes. All vessels were pressurized to 40 mmHg and kept at 378C. Contractile responses were studied after appropriate viability tests during cumulative addition of vasoactive agonists.
Fluorimetry
Arteries were loaded with FURA-2/AM, a calcium-sensitive dye. The dye was excited with light at 340 and 380 nm. The emission from the vessels was filtered at 520 nm, detected by a photomultiplier and acquired by a computer. Thereafter, the ratio of emission at both excitation wavelengths was calculated after subtraction of background fluorescence.
RNA extraction and qPCR
Arteries were isolated, quickly frozen, and stored at 2808C. Total RNA was extracted and the amount of RNA was quantified. Only samples of sufficient purity were processed for quantitative PCR.
Protein phosphorylation
To determine phosphorylation of the MYPT1 Ser695/Thr853 sites, VASP-Ser239 and MLC-Ser19, the vessels were subjected to similar protocols as in the contraction experiments. At the desired timepoints, the vessels were flash frozen by immersion in a 15% TCA/acetone slurry pre-cooled with dry ice and stored at 2808C followed by an acetone wash, homogenization in sample buffer and SDS -PAGE. 14 Phosphorylation was analysed with western blotting as detailed in Supplementary material online, Experimental Procedures.
Nitrite measurement in serum
Total serum nitrite and nitrate levels were measured by the Griess method. 15 In brief, samples were deproteinated, lipids were extracted, followed by incubation in 0.8% VCl 3 (reduction of nitrates to nitrites), 2% sulfanilamide and 0.1% N-naphthylethylenediamine. Optical densities were measured spectrophotometrically at 543 nm. Nitrite concentration values were obtained using calibration graphs for sodium nitrite (0.01 -30 mmol/L).
Statistical analysis
Contraction data were normalized to the maximal response observed during the first concentration-response relationship to the agonist. All data are expressed as mean + SEM; n represents the number of animals tested. Statistical significance with respect to time control was determined using Repeated Measures ANOVA. Statistical significances for protein phosphorylation levels and for relative mRNA expression were determined using unpaired Student's t-test (GraphPad) and REST software (QIAGEN), respectively. Statistical significance was reached at P , 0.05.
Results
3.1 In arteries of young rats methoxamine-induced contractions are attenuated by the endothelium Methoxamine (MX), a selective a 1 -adrenoceptor agonist not taken up by sympathetic nerves, 16 induced concentration-dependent contractions in endothelium-intact saphenous arteries from young and adult rats ( Figure 1) . Notably, MX-induced contractions of vessels from young rats exhibited a lower sensitivity compared with vessels from
Arterial functional remodelling in postnatal development adult rats ( Figure 1A) . The age-dependent difference in MX-induced contractions was absent in endothelium-denuded arteries ( Figure 1B) , i.e. was not related to smooth muscle cells. Endothelial removal abrogated the lower sensitivity of MX-induced contractions in arteries from young rats ( Figure 1C ), but did not modify MX-induced contractions in vessels from adult rats ( Figure 1D ). Collectively, these data show the existence of a prominent anti-contractile effect of the endothelium in young animals.
3.2 The endothelium-associated attenuation of MX-induced contractions in arteries of young rats is mediated by an active NO signalling pathway
One of the major mechanisms mediating endothelium-dependent relaxation is the NO pathway. Incubation of endothelium-intact arteries from young rats with 100 mmol/L L-NNA, a NO-synthase inhibitor, augmented the contractile response to MX in comparison to its inactive analogue D-NNA (100 mmol/L) ( Figure 2A) . Importantly, L-NNA did not affect the contractile response to MX in endothelium-denuded arteries from young rats (Supplementary material online, Figure S2A ), emphasizing the specificity of the effect of L-NNA. In contrast, this NO-synthase inhibitor only marginally affected the contractile response to MX in endothelium-intact arteries from adult rats (Supplementary material online, Figure S2B ). Moreover, incubation of isobaric preparations of endothelium-intact arteries from young rats with 100 mmol/L L-NNA also augmented the contractile response to MX in comparison to D-NNA (100 mmol/L) (Supplementary material online, Figure S2C ). In addition, incubation of endothelium-intact arteries from young rats with 1 mmol/L ODQ, an inhibitor of soluble guanylate cyclase (sGC), the key NO target in vascular smooth muscle, augmented the contractile response to MX in comparison to untreated vessels ( Figure 2B ). In some cases, NO-synthase was shown to produce not only nitric oxide, but also superoxide anion, that is converted to its metabolite H 2 O 2 and may mediate endothelium-dependent relaxation. 17 However, incubation of endothelium-intact arteries from young rats with 1000 U/mL catalase, a H 2 O 2 -inactivator, did not affect the attenuated contractile response to MX ( Figure 2C) .
The second signalling mechanism described in endothelial cells, which may lead to vessel relaxation, is the cyclooxygenase-prostacyclin pathway. 18 However, incubation of endothelium-intact arteries from young rats with 10 mmol/L indomethacin, a cyclooxygenase inhibitor, did not affect the attenuated contractile response to MX ( Figure 2D ). The third signalling mechanism mediating endothelium-dependent relaxation is the EDHF pathway. Although the nature of EDHF is still controversial, endothelial intermediate and small conductance calcium-activated potassium channels (IK Ca and SK Ca , respectively) are considered as absolutely necessary components of this pathway. 19, 20 The attenuated contractile response to MX in endothelium-intact arteries from young rats was not affected by incubation with 1 mmol/L TRAM-34, a specific IK Ca channel blocker (Supplementary material online, Figure S2D ), 0.1 mmol/L UCL1684, a specific SK Ca channel blocker (Supplementary material online, Figure S2E ), both substances together ( Figure 2E ) or both substances together after addition of 10 mmol/L indomethacin and 100 mmol/L L-NNA ( Figure 2F) ; the latter experiment was performed in order to remove a possible masking of the EDHF pathway by prostacyclin or NO production.
21 Figure 1 In the arteries of young rats, MX-induced contractions are attenuated by the endothelium. (A and B) Concentration-response relationships to MX of arteries from adult and young rats in the presence (A; n ¼ 10, 12; P , 0.05) and in the absence of the endothelium (B; n ¼ 7, 6; P ¼ 0.18). Note, that the MX-sensitivity in endothelium-intact arteries is lower in young compared with adult rats. (C and D) Concentration -response relationships to MX in endothelium-intact and denuded arteries from young (C; n ¼ 9, 9; P , 0.05) and adult (D; n ¼ 12, 11; P ¼ 0.58) rats. Removal of the endothelium shifts the dose-response curve to the left in young but not in adult rats.
3.3
The active NO-signalling pathway in young rats is due to functional changes in the endothelium but not in smooth muscle cells
The prominent NO-mediated endothelial attenuation of MX-induced contractions observed in vessels from young rats can be due to a high endothelial NO-synthase (eNOS) expression and/or activity. Indeed, the expression level of eNOS mRNA in vessels from young rats was considerably higher compared with vessels from adult rats ( Figure 3A) . mRNA of neuronal and inducible NOS were not found in these vessels although they were detected in samples from rat brain (neuronal NOS) and rat heart with ischaemia-reperfusion injury (inducible NOS), indicating functionality of the primers.
The PI3-kinase pathway is a major positive Ca 2+ -independent regulator of eNOS activity. 22 Since this pathway exists also in smooth muscle cells, 23 incubation of endothelium-denuded arteries from young rats with 10 mmol/L LY294002, a PI3-kinase inhibitor, reduced the contractile response to MX ( Figure 3B ). However, incubation of endothelium-intact arteries from young rats with the same concentration of LY294002 did not affect the attenuated contractile response to MX ( Figure 3C) . Consequently, at the endothelial level, LY294002 would augment the contractile response to MX, but this effect was masked by the LY294002-induced, smooth muscle-mediated reduction of the contractile response to MX. Another major regulator of eNOS activity is Ca 2+ carried into the cell by TRP channels or released from IP 3 -sensitive intracellular stores. 24 However, incubation of endothelium-intact arteries from young rats with 1 mmol/L ruthenium red, at this concentration blocking specifically TRPV4 channels recently shown to mediate calcium influx in endothelial cells, 25, 26 did not affect the attenuated contractile response to MX
(Supplementary material online, Figure S3A ). Further, incubation of 
endothelium-intact arteries from young rats with a higher concentration of ruthenium red (10 mmol/L), inhibiting many TRP channels expressed in endothelial cells, 27 did not affect the attenuated contractile response to MX ( Figure 3D) . Ruthenium red had also no effect on the contractile response to MX in endothelium-denuded vessels (Supplementary material online, Figure S3B ). In addition, incubation of endotheliumdenuded arteries from young rats with 10 mmol/L 2-APB, an inhibitor of IP 3 -mediated calcium release and the majority of TRP channels expressed in endothelial cells including those not affected by ruthenium red, 27, 28 reduced the contractile response to MX ( Figure 3E ). However, incubation of endothelium-intact arteries from young rats with the same concentration of 2-APB produced a similar effect on the contractile response to MX ( Figure 3F ). Therefore, we conclude that a change in Ca 2+ is unlikely to play a major role in producing the constitutive activity of eNOS in vessels from young animals. Recently, it was shown that eNOS activity can also be affected by a signal originating in smooth muscle cells upon vasoconstrictor action and transmitted to the endothelium through myoendothelial gap junctions (MEGJ). 12 However, incubation of endothelium-intact arteries from young rats with 100 mmol/L 18-a-glycyrrhetinic acid, a MEGJ blocker, did not affect the attenuated contractile response to MX in these vessels (Supplementary material online, Figure S3C ). Of note, an active endothelial NO production in adult rats may be functionally masked due to NO degradation by oxygen radicals. However, incubation of endothelium-intact arteries from adult rats with a combination of 1000 U/mL catalase and 140 U/mL superoxide dismutase (SOD-PEG) did not affect their contractile responses to MX (Supplementary material online, Figure S3D ).
In addition, the active NO-signalling pathway in vessels from young rats may be explained by a high responsiveness of the smooth muscle cells to NO due to either a fast production or a slow degradation of cGMP. However, relaxations of vessels induced by DEA-NO, a NO-donor, were not different in young and adult rats ( Figure 3G) . Similar results were obtained using SNP and SNAP as NO-donors (Supplementary material online, Figure S3E and F). Further, incubation of endothelium-intact arteries from both adult and young animals with 100 nmol/L sildenafil, an inhibitor of phosphodiesterase 5 (PDE5), decreased their contractile responses to MX in a similar manner (Supplementary material online, Figure S3G and H, respectively). In addition, the abundance of PKG, the central mediator of NO-induced effects in vascular smooth muscle cells, was not different in vessel homogenates from young and adult rats ( Figure 3H ).
The active NO signalling pathway in young rats is based on a constitutive eNOS activity
The NO-signalling pathway that attenuates MX-induced contractions in arteries of young rats can either possess constitutive activity or be activated by MX. To test for constitutive activity, endothelium-intact arteries were incubated with 100 mmol/L L-NNA or 1 mmol/L ODQ in the absence of MX. Both compounds induced tonic contractions in arteries from young but not from adult animals ( Figure 4A and B) . As probes for PKG activity, we determined phosphorylation of the PKG target sites on the regulatory subunit of myosin light chain phosphatase (MLCP), MYPT1, Ser695 and on vasodilator stimulated phosphoprotein, VASP, Ser239. 29, 30 Phosphorylation of these sites was considerably higher in endothelium-intact vessels from young compared with those from adult animals ( Figure 4C and D controls). Treatment of arteries from young animals with L-NNA reduced phosphorylation of these sites to levels comparable to those in adult arteries ( Figure 4C and D L-NNA). Phosphorylation of MYPT1-Ser695 and VASP-Ser239 was low in adult arteries and not changed by L-NNA ( Figure 4C and D) . Taken together, these data show that the active NO/sGC/PKG pathway in arteries from young rats is due to a constitutive eNOS activity. The L-NNA-induced tonic contractions of endothelium-intact arteries of young rats were associated with an increase in phosphorylation of the regulatory myosin light chain (MLC) at Ser19 (Figure 4E) , the site considered to be responsible for activation of smooth muscle contraction. 31, 32 This effect was not accompanied by an alteration of the intracellular calcium concentration in young as well as in adult rats (0.35 + 0.22% of R max 2 R min for young (n ¼ 6, P ¼ 0.17) and 0.29 + 0.19% of R max 2 R min for adult rats (n ¼ 7, P ¼ 0.17)), but associated with an increase in phosphorylation of MYPT1 at Thr853 ( Figure 4F ). MYPT1-Thr853 is phosphorylated by Rho kinase in smooth muscle tissue resulting in inhibition of MLCP. 33, 34 NO/sGC/PKG signalling reversed this inhibitory phosphorylation leading to de-inhibition of MLCP. 35 In our study, similar to previous reports, 35 was already significantly phosphorylated under basal conditions both in young and adult arteries, but only in young arteries phosphorylation of Thr853 was further increased by treatment with L-NNA ( Figure 4F ). This indicates that inhibition of MLCP activity is involved in mediating the tonic contraction. Our results suggest that in endothelium-intact arteries from young rats, the active NO/sGC/PKG signalling counteracts active RhoA/Rho kinase signalling which is unmasked by L-NNA.
Discussion

In arteries of young rats agonist-induced contractions are attenuated by the endothelium
The initial observation of our study was that the contractile response to MX in endothelium-intact saphenous arteries from young rats has a lower sensitivity compared with adults, while the responses of endothelium-denuded arteries were not different between the two age groups. This finding was supported by the observation that the sensitivity to MX was increased after endothelial removal in arteries from young but not adult animals. Thus, maturational changes in smooth muscle cells cannot explain the observed differences in MX-induced contractions of intact arteries. Of note, mechanical manipulations during endothelium denudation may have eliminated a small anti-contractile effect of the endothelium in arteries of adult animals. Indeed, L-NNA augmented the contractile response to MX in endothelium-intact arteries from adult animals. However, the effect of L-NNA was comparatively small, despite the fact that L-NNA almost completely abolished the relaxing effect to acetylcholine in vessels from adult as well as young animals demonstrating the existence of a potent NO-pathway in these vessels. Thus, these findings suggest that the age-dependent difference in MX-induced contractions of endothelium-intact arteries is due to developmental alterations in the function of the endothelium, whereby in young animals, the endothelium exerts a prominent anti-contractile effect.
Endothelial denudation in arteries from young animals increased the sensitivity not only to MX, but also to the thromboxane A 2 receptor agonist U46619 (Supplementary material online, Figure S4A ). Although both tested agonists activate GPCRs, these GPCRs are coupled to different G-proteins: a 1 -adrenoceptors are associated with G q/11 , while thromboxane A 2 receptors are associated with G 12/13 proteins that couple mainly to the phospholipase C/[Ca 2+ ] i -release/PKC-pathway and the RhoA/Rho-kinase-pathway, respectively. 31, 32 Thus, the anti-contractile effect of the endothelium in vessels from young animals seems to be independent of the nature of the contractile agonist and the receptor involved resulting in an endotheliumassociated attenuation of agonist-induced contractions.
The endothelium-associated attenuation of agonist-induced contractions in arteries of young rats is mediated by an active NO signalling pathway
The endothelium-associated attenuation of agonist-induced contractions in arteries of young animals may be caused by one or several endothelium-derived relaxing factors, i.e. nitric oxide, prostacyclin, or EDHF. For all these factors, functional remodelling during postnatal development has been described, albeit for endothelium-dependent vasorelaxation. 9,36 Consequently, we had to address them all in order to identify the mechanism(s) mediating the endothelium-associated attenuation of agonist-induced contractions in arteries of young animals. Inhibition of the cyclooxygenase/prostacyclin-or the EDHF-pathway did not affect the endothelium-associated attenuation of agonistinduced contractions in arteries from young animals. Conversely, inhibition of the NO-pathway considerably augmented the contractile responses to MX as well as to U46619 (Supplementary material online, Figure S4B ) and to KCl (Supplementary material online, Figure S4C ) in saphenous arteries from young animals. Of note, the Relative phosphorylation level of MYPT1 at Ser-695 and VASP at Ser-239 in endothelium-intact arteries from young and adult rats in the presence of vehicle (control) or 100 mmol/L L-NNA (n ¼ 6, 7; *P , 0.05 vs. control in adult rats; # P , 0.05 vs. control in young rats). Data were normalized to total MYPT1 (C) or to GAPDH (D) in maximally relaxed with DEA-NO vessels from young rats. (E and F) Relative phosphorylation level of MLC at Ser-19 and MYPT1 at Thr853 in endothelium-intact arteries from adult and young rats in the presence of vehicle or 100 mmol/L L-NNA (n ¼ 7, 10; #P , 0.05 vs. control in young rats). Data were normalized to total MLC (E) or total MYPT1 (F) and expressed in % of maximally contracted vessels (100 mmol/L L-NNA + 10 mmol/L MX) from young rats.
H 2 O 2 -inactivator catalase did not alter the contractile responses to MX in arteries from young animals showing that NO but not ROS produced by eNOS attenuates the agonist-induced contractile responses in arteries from young animals. In addition, an increase of the contractile response to MX after inhibition of the NO-pathway was also observed in the A. poplitea (Supplementary material online, Figure S5A-C) . In summary, the novel observation of the present study is that in arteries from young animals only endothelium-derived NO mediates the endothelium-associated attenuation of agonist-induced contractions.
Developmental changes of the endothelium have been reported previously only for its anti-contractile effect on pressure-induced tone 37, 38 and for agonist-induced endothelium-dependent relaxations. 9, 10, 39, 40 For example, during postnatal development, a NO-dependent anti-contractile effect of the endothelium on pressure-induced tone was found to increase with age in murine cerebral arteries 38 or to decrease with age in swine mesenteric arteries. 37 Further, the NO-mediated part of vasodilator-induced endothelium-dependent relaxations was shown to be augmented with age in rat skeletal muscle arterioles, 39 swine cerebral pial arterioles, 9 and ovine cerebral arteries 40 or to decline with age in swine mesenteric arteries. 10 Thus, different developmental changes have been observed for NO-mediated endothelium-dependent relaxations and for NO-mediated anticontractile effects of the endothelium on pressure-induced tone. These differences may correlate with functional changes in the particular growing organ, but their precise reasons are not clear at the moment. Our study significantly extends previous findings by showing that developmental changes can also be observed for the anti-contractile effect of the endothelium on agonist-induced contractions. This effect of the endothelium is of special importance, because agonist-induced tone is always present over the whole period of postnatal live, realized mostly by sympathetic nerve activation in adulthood or by humoral influences in childhood where the sympathetic nervous system is not yet fully active. 41, 42 Moreover, in contrast to pressure-induced tone, that is restricted to myogenically active small arteries and arterioles, agonist-induced tone is present in vessels of almost all calibres. In this study, the saphenous and popliteal arteries were used because these conduit arteries permit the investigation of agonist-induced tone without interference from pressure-induced tone. More importantly, they regulate blood flow to a large area of downstream smaller vessels supplying the skin as well as a large number of skeletal muscles of the hindlimb. These regions receive a significant part of cardiac output in young animals. 43 Moreover, total nitrite concentration in blood serum of young animals was significantly higher in comparison to adult animals (Supplementary material online, Figure S5D ), indirectly indicating that total NO production by the vasculature is higher in young rats. In conclusion, the much stronger endothelium-mediated attenuation of agonist-induced contractions in young compared with adult animals represents an important example of functional remodelling during postnatal development and may serve as an essential and common mechanism restricting arterial contraction in young animals. In order to better understand the functional role of the stronger endothelium-mediated attenuation of agonist-induced contractions in young compared with adult animals, we transformed our data on the MX-induced change in vessel tension to data showing the MX-induced change in transmural pressure using the Laplace relationship (Supplementary material online, Figure S6 ). These data indicate that vessels from young animals have a smaller ability to develop pressure compared with vessels from adult animals. Thus, our data are consistent with the idea that vascular smooth muscle contractility is weaker in young compared with adult animals. Notably, the diminished ability to develop pressure in young rats is more prominent in endothelium-intact vessels compared with endothelium-denuded vessels (Supplementary material online, Figure S6 ). This finding indicates that the constitutive activity of the endothelium in young rats is required, as an additional mechanism, to get the final low blood pressure observed in these animals. Further, it provides additional regulatory options for setting blood pressure in young animals.
4.3
The NO-mediated endothelium-associated attenuation of agonist-induced contractions in young rats is due to functional changes in endothelial but not smooth muscle cells
In adult animals, a strong, NO-mediated endothelium-associated attenuation of agonist-induced contractions may well be present but functionally suppressed because of NO degradation by oxygen radicals. However, this scenario seems unlikely because the prevention of NO degradation by catalase and superoxide dismutase did not unmask a strong endothelium-associated attenuation of contractions in arteries from adult rats.
The NO-mediated endothelium-associated attenuation of agonistinduced contractions in arteries from young animals may be due to either a high NOS expression/activity in endothelial cells or a high responsiveness of smooth muscle cells to NO. Concerning the latter hypothesis, our data show that (i) the sensitivity to several NO-donors, (ii) the effect of the PDE5-inhibitor sildenafil on MX-induced contractions, and (iii) PKG protein abundance are not different in vessels from young and adult rats. These findings are supported by reports in the literature showing an absence of age-dependent differences in vascular smooth muscle responsiveness to NO-donors. 9, 10 Thus, the data indicate that the NO-mediated endothelium-associated attenuation of agonist-induced contractions in arteries from young animals is not due to functional changes of NO-dependent signal transduction mechanisms in smooth muscle cells. In contrast, eNOS expression at the mRNA level was much higher in vessels from young compared with adult rats. Age-dependent differences in eNOS expression/activity have been reported previously, where increases, 44 ,45 a decrease, 46 and no change with age 47 were observed, depending on the vascular bed under investigation. In summary, these data demonstrate that the NO-mediated endotheliumassociated attenuation of agonist-induced contractions in arteries from young animals is due to functional changes of NO-related signal transduction mechanisms in endothelial cells.
4.4
The active NO signalling pathway in young rats is based on a constitutive eNOS activity
We observed that eNOS blockade in the absence of any contractile agent caused an increase of MLC phosphorylation and of vessel tension in endothelium-intact arteries from young rats, that was absent in vessels from adult animals. Further, an increase of vessel tension in the absence of any contractile agent was observed also after blockade of guanylate cyclase. Moreover, the basal phosphorylation levels of MYPT1 at Ser-695 and VASP at Ser-239, i.e. PKG activity, were considerably higher in endothelium-intact arteries from young compared with adult rats. In addition, L-NNA in the absence of MX reduced the phosphorylation of MYPT1 at Ser-695 and of VASP at Ser-239 in arteries from young but not from adult animals, whereas it increased the Rho-kinase-dependent phosphorylation of MYPT1 at Thr853. The later was not accompanied by a change in the intracellular calcium concentration, consistent with the idea that force is suppressed by inhibition of RhoA via NO/cGC/PKG signalling. 30, 48 Together these data indicate that the basal activity of PKG and, hence, of the whole NO pathway is much higher in arteries of young compared with adult animals. This finding leads to the question what mechanism is responsible for the difference in NO pathway activity. The latter is controlled to a large extent by the level of blood flow. Unfortunately, data on the blood flow as well as on many other known factors influencing NO pathway activity in hindlimb arteries of adult and young animals have not been reported in the literature. Due to the large amount of experimental series required to determine the mechanism responsible for the difference in NO pathway activity, this question has to be addressed in future studies. In summary, our data strongly support the idea that a constitutive eNOS activity underlies the active NO signalling pathway mediating the endothelium-associated attenuation of agonist-induced contractions in arteries of young rats.
In conclusion, we demonstrated that agonist-induced contractions in arteries of young rats are attenuated by the endothelium possessing an active NO-pathway (Supplementary material online, Figure S7 ). The active NO-pathway is due to a constitutive eNOS activity that disappears with age. Thus, these findings show that endothelial function undergoes maturational changes, reflecting the processes of functional remodelling during early postnatal development. The endotheliumassociated attenuation of agonist-induced contractions in arteries of young animals may contribute to the lower blood pressure observed in young compared with adult animals. 49 In addition, the constitutive NO-release and subsequent PKG activation might modulate proliferative processes within the smooth muscle cells leading, for example, to the augmentation of the expression of proteins representative for the differentiated smooth muscle cell phenotype. 50 
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